C. H. Robinson Worldwide
CHRW
$181.61
+8.05%
C.H. Robinson Worldwide, Inc. is a leading non-asset-based third-party logistics (3PL) provider operating within the Integrated Freight & Logistics industry. The company's core business involves domestic freight brokerage, which constitutes about 60% of net revenue and includes truck brokerage and rail intermodal, complemented by a significant air and ocean forwarding division (30%) and a legacy produce-sourcing operation. As a top-tier platform company, it distinguishes itself through its extensive global network and technology-driven logistics solutions, acting as a critical intermediary between shippers and carriers. The current investor narrative is dominated by the stock's dramatic price recovery from cyclical lows, reflecting a debate on whether the rebound is a sustainable turnaround driven by operational improvements and cost discipline or a temporary bounce within a still-challenging freight market, as highlighted by recent market volatility and sector rotation discussions.…
CHRW
C. H. Robinson Worldwide
$181.61
Investment Opinion: Should I buy CHRW Today?
Rating: Hold. The core thesis is that CHRW's powerful price recovery has largely priced in an expected earnings turnaround, leaving limited near-term upside and elevated risk if fundamental improvements disappoint.
Supporting this view are four key data points: 1) The stock trades at a forward P/E of 22.88x, implying significant EPS growth to $7.24, but is already near the implied consensus price target of ~$165. 2) Revenue growth remains negative at -6.5% YoY, providing no fundamental tailwind. 3) While free cash flow is strong at $894.9M TTM, net margin has compressed year-over-year. 4) The technical picture shows a sharp recent pullback (-6.99% over 1 month) after a massive rally, suggesting a consolidation phase.
The thesis would upgrade to a Buy if revenue growth turns positive and gross margins stabilize above 8.5%, providing concrete evidence of a cyclical upturn. It would downgrade to a Sell if the stock breaks below key support at $160 on sustained volume, signaling a failed breakout, or if forward EPS estimates are revised downward materially. Relative to its history and the current fundamental backdrop, the stock appears fairly valued to slightly overvalued, with the market paying a premium for anticipated recovery that is not yet evident in the reported numbers.
Sign up to view all
CHRW 12-Month Price Forecast
The outlook for CHRW is one of high uncertainty balanced by solid financials. The stock has run far ahead of its current fundamentals on hopes of a cyclical recovery, creating a 'show me' story for the next 12 months. The base case (50% probability) of range-bound trading is most likely, as the company's strong cash flow and efficiency likely prevent a collapse, but the top-line headwinds prevent a re-acceleration. The stance is neutral because the risk/reward appears balanced at the current price near implied fair value. We would upgrade to bullish on confirmation of revenue growth inflection and margin expansion, likely requiring two consecutive quarters of improvement. We would downgrade to bearish on a breakdown below $160 coupled with downward EPS revisions, which would signal the recovery thesis is failing.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on C. H. Robinson Worldwide's 12-month outlook, with a consensus price target around $236.09 and implied upside of +30.0% versus the current price.
Average Target
$236.09
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$145 - $236
Analyst target range
Analyst coverage for CHRW is limited, with only 3 analysts providing estimates, indicating it may be under-followed relative to its market cap, which can lead to higher volatility. The consensus leans bullish, with recent institutional ratings from firms like Evercore ISI Group (Outperform), B of A Securities (Buy), and Wells Fargo (Overweight) supporting a positive outlook. The average target price is not explicitly provided in the data, but the estimated EPS average is $7.24, which, against a forward P/E of 22.88x, implies a price target in the $165-$166 range, suggesting the stock is currently trading near consensus fair value. The target range, inferred from estimated EPS, spans from a low of $6.81 to a high of $8.08. The high-end target likely assumes a successful execution of cost-saving initiatives, a rebound in freight volumes, and multiple expansion. The low-end target likely prices in a prolonged freight recession, continued margin pressure, and potential market share loss. The recent pattern of analyst actions shows stability, with no downgrades in the latest batch of ratings from January and February 2026, suggesting maintained conviction following the company's quarterly updates. However, the low number of covering analysts means this sentiment signal should be weighed cautiously.
Bulls vs Bears: CHRW Investment Factors
The evidence presents a tense battle between a powerful technical recovery and still-challenging fundamentals. The bull case is anchored by the stock's dramatic 81% yearly surge, strong free cash flow generation, and high capital efficiency, suggesting the market is front-running an operational turnaround. The bear case highlights that this optimism is not yet reflected in the financials, with revenue declining -6.5% YoY and margins compressed, all while the stock trades at a historically elevated trailing P/E of 32.93x. Currently, the bull side has stronger evidence due to the sheer magnitude of the price recovery and the company's robust financial health, but the bearish fundamental pressures are substantial. The single most important tension is whether CHRW's current valuation, which prices in a significant earnings rebound (forward P/E 22.88x), will be justified by an actual inflection in freight market dynamics and margin expansion in the coming quarters, or if it represents an over-optimistic premium vulnerable to correction.
Bullish
- Powerful 1-Year Price Recovery: The stock has surged 81.11% over the past year, dramatically outperforming the SPY's 29.52% gain. This technical breakout from cyclical lows suggests a major shift in market sentiment, pricing in a significant earnings recovery and operational turnaround.
- Strong Free Cash Flow & Balance Sheet: The company generates robust TTM free cash flow of $894.9 million, comfortably covering its 51.33% dividend payout ratio. With a current ratio of 1.53 and a manageable debt-to-equity of 0.88, CHRW possesses the financial stability to navigate the freight cycle downturn and return capital to shareholders.
- High Capital Efficiency: Return on Equity (ROE) stands at a strong 31.81% and Return on Assets (ROA) at 10.05%. These metrics demonstrate the company's efficient use of capital and its platform-based, non-asset model's ability to generate high returns even during a revenue contraction.
- Analyst Conviction on Earnings Recovery: The forward P/E of 22.88x is significantly lower than the trailing P/E of 32.93x, implying the market expects a substantial EPS rebound to an estimated $7.24. Recent analyst ratings from firms like B of A Securities (Buy) and Wells Fargo (Overweight) support this positive forward outlook.
Bearish
- Persistent Revenue Decline: Q4 2025 revenue of $3.91B represents a -6.5% YoY decline, continuing a sequential downtrend from $4.14B in Q3. This underscores ongoing top-line pressure in the core freight brokerage market, with no clear sign of a cyclical bottom in volumes or pricing.
- Elevated Valuation with Compressed Margins: The trailing P/E of 32.93x is historically high for CHRW, yet net margin has compressed to 3.48% in Q4 2025 from 3.57% a year prior. This creates a valuation risk where the stock is priced for a sharp margin recovery that has not yet materialized in the financials.
- Recent Sharp Technical Pullback: The stock is down -6.99% over the past month and -4.26% over three months, including a -6.71 point drop on April 10th. This divergence from the strong yearly trend signals near-term selling pressure and potential exhaustion after the powerful rally, with the price now testing key support near $160.
- Limited Analyst Coverage & High Short Interest: With only 3 analysts providing estimates, the stock is under-followed, which can lead to higher volatility and less consensus clarity. A short ratio of 3.42 indicates significant bearish bets against the sustainability of the recent rally, reflecting skepticism in the market.
CHRW Technical Analysis
The stock is in a sustained, powerful uptrend over the past year, evidenced by a 1-year price change of +81.11%, but is currently experiencing a significant pullback from recent highs. With a current price of $163.49, it is trading at approximately 66% of its 52-week range ($86.58 to $203.34), indicating a retreat from the highs but still positioned well above the midpoint, suggesting the long-term bullish structure remains intact despite recent weakness. Recent short-term momentum has turned sharply negative, with the stock down -6.99% over the past month and -4.26% over the past three months, which starkly contrasts with the powerful yearly gain and signals a potential consolidation or correction phase after the steep ascent. This divergence, coupled with a beta of 0.935 indicating slightly lower volatility than the broader market, suggests the stock may be undergoing a healthy mean reversion rather than a trend reversal, though the sharp -6.71 point drop on April 10th underscores heightened near-term selling pressure. Key technical support is anchored at the 52-week low of $86.58, but more immediate support lies in the $160-$170 zone where the price has recently consolidated. The primary resistance is the 52-week high of $203.34, a level the stock approached in early February before the sharp selloff. A decisive breakout above $203.34 would signal a resumption of the primary bull trend, while a sustained breakdown below the $160 level could indicate a deeper correction toward the next support. The stock's beta of 0.935 implies it is about 6.5% less volatile than the SPY, which is notable given its large yearly move and suggests its recent swings, including a max drawdown of -19.45%, are somewhat contained relative to its own momentum.
Beta
0.94
0.94x market volatility
Max Drawdown
-19.4%
Largest decline past year
52-Week Range
$87-$203
Price range past year
Annual Return
+102.1%
Cumulative gain past year
| Period | CHRW Return | S&P 500 |
|---|---|---|
| 1m | +5.8% | +4.6% |
| 3m | +3.3% | +1.4% |
| 6m | +42.6% | +5.6% |
| 1y | +102.1% | +33.5% |
| ytd | +10.9% | +2.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CHRW Fundamental Analysis
Revenue growth remains under pressure, reflecting a challenging freight environment, with Q4 2025 revenue of $3.91 billion representing a -6.5% year-over-year decline. The multi-quarter trend shows revenue has sequentially declined from $4.14 billion in Q3 2025 and $4.14 billion in Q2 2025, indicating persistent top-line headwinds. Segment data reveals the core 'Transportation Customer’s Freight' business generated $3.57 billion in the latest period, dwarfing the 'Sourcing' segment's $340.9 million, implying the overall growth trajectory is heavily tied to the cyclical brokerage market. The company remains profitable but with compressed margins compared to the prior year. Q4 2025 net income was $136.3 million, yielding a net margin of 3.48%, which is down from the 3.57% net margin in Q4 2024. Gross margin for the quarter was 8.18%, a sequential improvement from 8.62% in Q3 2025 but below the 8.69% gross margin from Q2 2025, indicating some stabilization at lower levels. The operating margin of 4.64% in Q4 2025 shows the company is maintaining operational profitability despite the revenue decline, a key focus for investors. Balance sheet health is solid, with a strong current ratio of 1.53 and a manageable debt-to-equity ratio of 0.88. The company generates robust free cash flow, with TTM free cash flow of $894.9 million, providing ample liquidity to fund operations and shareholder returns. Return on Equity (ROE) is a healthy 31.81%, and Return on Assets (ROA) is 10.05%, indicating efficient use of capital. The strong free cash flow, which significantly covers the dividend payout ratio of 51.33%, underscores a financially stable enterprise capable of weathering the cyclical downturn.
Quarterly Revenue
$3.9B
2025-12
Revenue YoY Growth
-0.06%
YoY Comparison
Gross Margin
+0.08%
Latest Quarter
Free Cash Flow
$894891000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CHRW Overvalued?
Given the positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 32.93x, while the forward P/E is 22.88x, based on estimated EPS of $7.24. The significant gap between trailing and forward multiples implies the market expects a substantial recovery in earnings over the next twelve months, pricing in an improvement from current depressed profitability levels. Compared to sector averages, CHRW's valuation presents a mixed picture. Its trailing P/E of 32.93x is elevated, but its Price-to-Sales (PS) ratio of 1.19x and EV/Sales of 1.32x are more moderate. The forward P/E of 22.88x will be the critical gauge; if the industry average forward P/E is materially lower, CHRW may be trading at a premium justified only by its market-leading position and potential for margin recovery if the freight cycle turns. Historically, the stock's current trailing P/E of 32.93x sits above its own recent historical range, as seen in quarterly data where P/E ratios have fluctuated from the mid-teens to over 80x during the earnings trough. For instance, the P/E was 20.86x at the end of 2024 and 35.34x at the end of Q4 2025. Trading near the higher end of its own historical band suggests the market has already priced in a meaningful earnings recovery, leaving limited room for multiple expansion and increasing sensitivity to any earnings disappointments.
PE
32.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 9x~83x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
23.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the company's exposure to the highly cyclical freight brokerage market, which constitutes about 60% of net revenue. The persistent -6.5% YoY revenue decline in Q4 2025, coupled with a net margin compression to 3.48%, demonstrates sensitivity to economic slowdowns and pricing pressure. While the balance sheet is strong, the elevated trailing P/E of 32.93x creates valuation risk; if the anticipated earnings recovery (implied by the forward P/E of 22.88x) fails to materialize, the stock is vulnerable to significant multiple compression. The company's profitability remains heavily dependent on a turnaround in the freight cycle.
Market & Competitive Risks include the stock's premium valuation relative to its own recent history, trading near the higher end of its historical P/E band. With a beta of 0.935, it is slightly less volatile than the market, but its 81% yearly surge makes it susceptible to profit-taking and sector rotation, as hinted by recent news discussing a shift away from 'automation-vulnerable' sectors. Competitive disruption from digital freight brokers and ongoing industry capacity imbalances pose external threats to pricing power and market share, which could delay margin recovery.
Worst-Case Scenario involves a prolonged freight recession coupled with a failure of cost discipline to protect margins, leading to consecutive earnings misses. This could trigger analyst downgrades from the current bullish stance and a rapid de-rating of the forward multiple. A realistic downside could see the stock re-test its recent consolidation lows near $160, and in a severe adverse scenario, fall toward the next major support level, representing a potential decline of -20% to -25% from the current price of $163.49, aligning with the stock's recent max drawdown of -19.45%.
FAQ
The key risks are: 1) Cyclical/Market Risk: Continued weakness in the freight brokerage market, which drives 60% of revenue, leading to further top-line declines. This is evidenced by the sequential revenue drop from $4.14B to $3.91B. 2) Valuation Compression Risk: The stock's high trailing P/E of 32.93x makes it vulnerable if the anticipated earnings rebound falters, potentially triggering a sharp de-rating. 3) Execution Risk: Failure to maintain cost discipline, leading to further margin pressure below the current 3.48% net margin. 4) Sentiment & Liquidity Risk: With only 3 covering analysts and a short ratio of 3.42, the stock can be prone to exaggerated moves on news or shifts in sector rotation.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees range-bound trading between $160 and $175, assuming the freight market remains sluggish but CHRW maintains profitability. The Bull Case (30% probability) targets $185 to $203, requiring a clear cyclical upturn and margin expansion. The Bear Case (20% probability) warns of a drop to $140-$160 if the recovery disappoints and estimates are cut. The most likely outcome is the Base Case, as the stock consolidates its massive gains while investors wait for fundamental confirmation. The key assumption is that the $7.24 consensus EPS estimate for the forward year is achievable.
CHRW appears fairly valued to slightly overvalued based on current fundamentals. The trailing P/E of 32.93x is historically elevated for the company, especially against a backdrop of declining revenue (-6.5% YoY) and compressed net margins (3.48%). The forward P/E of 22.88x, based on estimated EPS of $7.24, implies the market is paying a premium for a significant earnings recovery that has not yet occurred. Compared to sector averages, its Price-to-Sales ratio of 1.19x is moderate. The valuation implies the market expects a successful turnaround; it is not pricing in a discount, leaving little room for error.
CHRW is a Hold, not a clear-cut buy at the current price. For investors who already believe the freight cycle is poised for a sharp recovery in the next 6-12 months, the stock offers leveraged exposure through a high-quality platform. However, with the stock up 81% in a year and trading near its implied fair value of ~$165, most of the recovery may already be priced in. The 1.56% dividend yield and strong free cash flow provide some downside protection, but the key risk is that revenue continues to decline, disappointing the market's high expectations embedded in the 22.88x forward P/E. It could be a good buy on a significant pullback toward stronger support levels.
CHRW is primarily suited for a medium-to-long-term investment horizon of 12-18 months or more. This is a cyclical play on the freight market recovery, which typically unfolds over quarters, not weeks. The stock's beta of 0.935 suggests its volatility is roughly in line with the market, but its recent 81% surge and subsequent pullback indicate it can be volatile around earnings and economic data, making it challenging for short-term traders. The company pays a modest but well-covered dividend (1.56% yield), adding an income component for long-term holders. Given the 'show me' story, investors should be prepared to hold through potential volatility while the fundamental thesis plays out.